Treprostinil Tillomed 1 mg/ml otopina za infuziju क्रोएशिया - क्रोएशियाई - HALMED (Agencija za lijekove i medicinske proizvode)

treprostinil tillomed 1 mg/ml otopina za infuziju

tillomed pharma gmbh, mittelstrasse 5/5a, schonefeld, njemačka - treprostinil - otopina za infuziju - 1 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 1 mg treprostinila u obliku treprostinilnatrija

Treprostinil Tillomed 2,5 mg/ml otopina za infuziju क्रोएशिया - क्रोएशियाई - HALMED (Agencija za lijekove i medicinske proizvode)

treprostinil tillomed 2,5 mg/ml otopina za infuziju

tillomed pharma gmbh, mittelstrasse 5/5a, schonefeld, njemačka - treprostinil - otopina za infuziju - 2,5 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 2,5 mg treprostinila u obliku treprostinilnatrija

Treprostinil Tillomed 5 mg/ml otopina za infuziju क्रोएशिया - क्रोएशियाई - HALMED (Agencija za lijekove i medicinske proizvode)

treprostinil tillomed 5 mg/ml otopina za infuziju

tillomed pharma gmbh, mittelstrasse 5/5a, schonefeld, njemačka - treprostinil - otopina za infuziju - 5 mg/ml - urbroj: 1 ml otopine za infuziju sadrži 5 mg treprostinila u obliku treprostinilnatrija

Innovax-ND-ILT यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

innovax-nd-ilt

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunološki za aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Voxzogo यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

voxzogo

biomarin international limited - vosoritide - achondroplasia - lijekovi za liječenje bolesti kostiju - voxzogo is indicated for the treatment of achondroplasia in patients 4 months of age and older whose epiphyses are not closed. the diagnosis of achondroplasia should be confirmed by appropriate genetic testing.